 |
|
Auxilium’s core competency lies in the development and commercialization of therapeutics that address unmet medical needs. Given our corporate strategy of focusing resources outside of discovery activities, we rely on our business development group to serve this crucial function of sourcing innovation. In fact, Auxilium’s product and pipeline candidates have all been derived from licensing partnerships. Furthermore, collaborations enable Auxilium to maximize the value of its products once approved. For example, we introduced Testim®1% in territories where we had not established a commercial presence by entering into partnerships with leading companies in these geographies. Building alliances with complementary partners underlies our accomplishments to date and will ensure our future success. If you wish to obtain additional information about available opportunities or present us with a potential collaboration, we invite you to contact our business development group.
|
